This content is machine translated "Medication Overuse Headache" (MOH). What does the updated S1 guideline say? The 2022 updated guideline incorporates the latest recommendations of the International Headache Society as well as current study findings on drug interventions. Antibodies directed against CGRP or its receptor have…
